RÉSUMÉ DIGEST
ACT 424 (HB 391) 2021 Regular Session Magee
Existing law authorizes physicians who are licensed by and in good standing with the La.
State Board of Medical Examiners to recommend marijuana for therapeutic use, known
commonly as "medical marijuana", by patients clinically diagnosed as suffering from any
debilitating medical condition defined in existing law.
Prior law provided that physicians may recommend medical marijuana in any form allowed
by the rules and regulations of the La. Board of Pharmacy except for the following forms:
(1) Inhalation form.
(2) Raw or crude form.
New law repeals the prohibition on medical marijuana in inhalation form and raw or crude
form provided in prior law.
New law prohibits pharmacies authorized by existing law to dispense medical marijuana
from doing any of the following:
(1) Dispensing more than two and one-half ounces (71 grams) of raw or crude marijuana
every 14 days to any individual patient.
(2) Dispensing raw or crude marijuana to any person under 21 years of age without a
written order from a physician specifically recommending marijuana in raw or crude
form for that person.
Existing law requires the La. Board of Pharmacy to establish, through administrative rules,
standards, procedures, and protocols to ensure that medical marijuana dispensed is
consistently pharmaceutical grade. New law creates an exception to this requirement and
provides that raw or crude marijuana is not subject to these standards, procedures, and
protocols.
Effective January 1, 2022.
(Amends R.S. 40:1046(A)(1) and (C)(2)(e); Adds R.S. 40:1046(A)(5) and (C)(2)(l))


Statutes affected:
HB391 Original: 40:1046(A)(1)
HB391 Engrossed: 40:1046(A)(1)
HB391 Enrolled: 40:1046(A)(1)
HB391 Act 424: 40:1046(A)(1)